{"nct_id":"NCT03265119","title":"PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations","status":"COMPLETED","status_verified_date":"2021-07","start_date":"2017-08-28","start_date_type":"ACTUAL","primary_completion_date":"2018-09-24","primary_completion_date_type":"ACTUAL","completion_date":"2018-10-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AVTX"]}